Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biosimilars: opportunity or cause for concern?

Simon D Roger1, Ashraf Mikhail

  • 1Department of Renal Medicine, Gosford Hospital, Australia. sroger@nsccahs.health.nsw.gov.au

Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques
|August 31, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Longitudinal Assessment of Health-Related Quality of Life in Adults with CKD.

Kidney360·2025
Same author

Participant Perceptions of Increasing Water Intake in Polycystic Kidney Disease.

Kidney international reports·2025
Same author

Lorundrostat in Participants With Uncontrolled Hypertension and Treatment-Resistant Hypertension: The Launch-HTN Randomized Clinical Trial.

JAMA·2025
Same author

Non-Inferiority of Subcutaneous Efepoetin Alfa Compared to Methoxy Polyethylene Glycol-Epoetin Beta in Stage 3 or 4 CKD Patients: Insights From a Phase 3 Trial.

Nephrology (Carlton, Vic.)·2025
Same author

UK kidney association clinical practice guideline: update of anaemia of chronic kidney disease.

BMC nephrology·2025
Same author

Preferences in treating polyomavirus infection in kidney transplant recipients: A discrete choice experiment with patients, caregivers, and clinicians.

Transplant infectious disease : an official journal of the Transplantation Society·2024
Same journal

Old drugs, new weapons: current trends in repurposing therapies against antimicrobial resistance.

Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques·2026
Same journal

Dissolution-permeation approach for biopharmaceutical evaluation: a feasibility study using naproxen.

Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques·2026
Same journal

Practical considerations for managing patients being treated with topical roflumilast.

Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques·2026
Same journal

Artificial intelligence directed computational protein design: lessons from COVID-19 for pandemic-ready vaccines and antibody therapeutics.

Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques·2026
Same journal

Qualitative phytochemical profiling, antioxidant activity, and development of a water-in-oil cream containing combined oil and water infusions of frankincense resin (<i>Boswellia spp.</i>): a preliminary <i>in vitro</i> study.

Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques·2026
Same journal

Ketamine enhancement of dexmedetomidine attenuation of methamphetamine-induced agitation in rats.

Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques·2026
See all related articles

Biosimilars, or follow-on biologics, offer potential cost savings as patents expire. However, ensuring their safety and efficacy compared to originator biopharmaceuticals requires careful manufacturing, quality control, and regulatory oversight.

Area of Science:

  • Biotechnology
  • Pharmaceutical Sciences
  • Regulatory Affairs

Background:

  • Biopharmaceuticals, derived from biotechnology, have transformed disease treatment.
  • Expiring biopharmaceutical patents create opportunities for follow-on products, known as biosimilars.
  • The growing biosimilar market presents significant commercial interest and challenges.

Purpose of the Study:

  • To review the key issues surrounding the development and approval of biosimilars.
  • To examine manufacturing, quality control, and clinical efficacy considerations for biosimilars.
  • To explore the evolving regulatory landscape for biosimilar products.

Main Methods:

  • Literature review of scientific publications and regulatory guidelines.
  • Analysis of manufacturing processes and quality control standards for biosimilars.

Related Experiment Videos

  • Evaluation of clinical data regarding efficacy and side effects of biosimilar products.

    • Main Results:

    • Biosimilar development requires rigorous comparability studies to originator products.
    • Quality control is paramount to ensure biosimilar safety and efficacy.
    • Regulatory pathways are adapting to address the unique challenges of biosimilar approval.

    Conclusions:

    • Biosimilars present a complex interplay of therapeutic potential, manufacturing challenges, and regulatory frameworks.
    • Ensuring patient safety and therapeutic equivalence is critical for biosimilar market integration.
    • Ongoing evolution of regulations is necessary to manage the risks and benefits of biosimilars.